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Monday, February 17, 2014 329aconduction and QT prolongation observed in SUDEP and that TTX-sensitive
channels play an important role in these changes. Our results suggest a new
paradigm by which some of the arrhythmias observed during epilepsy are
not centrally mediated but also occur as a consequence of electrical remodel-
ing of the heart.
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Rad/Rem/Rem2/Gem (RGK) proteins are Ras-like monomeric G-proteins that
powerfully potently inhibit all high-voltage-activated CaV1 and CaV2 calcium
channels. Since all RGKs bind auxiliary CaVbs it was generally assumed that
the RGK-b interaction is essential for CaV channel inhibition. Recently, using
a mutated b (bTM) which), which selectively loses the ability to interact with
RGKs, we reported that Rem inhibits CaV1.2 channels using both b-binding-
dependent and direct a1-binding-dependent mechanisms (Yang et al, 2013,
PLoS One, 7:e37079). Our aims here were twofold: (1) to identify determinants
and mechanisms underlying direct Rem binding to, and inhibition of, CaV1.2
pore-forming a1C subunit;; (2) to profile the relative prevalence of b-bind-
ing-dependent and -independent mechanisms of inhibition across the RGK
and CaV1/CaV2 channel families. Using a combination of FRET, co-
immunoprecipitation assays, systematic truncations, and whole-cell electro-
physiology we found that Rem C-terminus interacts with a1C N-terminus to
inhibit CaV1.2 current (ICa,L) and gating charge. For profiling, we compared
the impact of the four RGKs on currents through recombinant channels
(CaV1.3, CaV2.1, CaV2.2) reconstituted with either wt b2a or b2a,TM, respec-
tively. When reconstituted with wt b2a, all three channel types were strongly
inhibited by each RGK. By contrast, when reconstituted with b2a,TM, CaV1.3
and CaV2.1 were completely refractory to all four RGKs indicating these chan-
nels display only CaVb-binding-dependent mechanisms of inhibition. CaV2.2
channels reconstituted with b2a,TM displayed a strong inhibition solely to
Rad, identifying a second example of CaVb-binding-independent regulation
of a CaV channel by an RGK protein. The results reveal latent capabilities of
distinct RGKs to selectively inhibit particular CaV1/CaV2 channels in an
isoform-specific manner. These dormant capabilities may be exploitable to
develop novel genetically-encoded isoform-selective CaV1/CaV2 channel
inhibitors.
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Leucine-rich repeat containing 10 (LRRC10) is a cardiac-specific protein that
plays a critical role in cardiac function. We have demonstrated that the Lrrc10-
null (Lrrc10-/-) mice develop dilated cardiomyopathy. Our recent data indicate
that Lrrc10-/- cardiomyocytes exhibit reduced L-type Ca2þ channel (LTCC)
current (ICa,L). However, it is unclear how LRRC10 regulates ICa,L in the heart.
To investigate the role of LRRC10 in the regulation of LTCCs, we co-
expressed the Myc tagged LRRC10 (LRRC10-Myc), heamagglutinin tagged
Cav1.2 (Cav1.2-HA) and the auxiliary Cavb2C subunit in HEK293 cells and per-
formed co-immunoprecipitation (co-IP) on lysates using either anti-HA, anti-
Myc antibody or control IgG. Western blot analysis demonstrated that
Cav1.2 and LRRC10 associated with one another without the co-expression
of Cavb2C subunit. Also, the Cavb2C and LRRC10 did not co-IP with one
another suggesting that the LRRC10 may directly interact with Cav1.2 subunit.
We then tested if a single point mutation H150A or triple point mutations
Y104A, W127A and H150A would alter putative functional interaction sites
in the LRRC10 and investigated if these mutations disrupt LRRC10 association
with Cav1.2. Both LRRC10 mutants did not associate with Cav1.2. Addition-
ally, co-IP analysis using mouse ventricular homogenates demonstrated that
LRRC10 and Cav1.2 subunit are associated with one another. Finally, whole-
cell patch clamp experiments performed in ventricular myocytes from
Lrrc10-/- mice demonstrated a significant reduction in the ICa,L density (2.5
0.2 pA/pF) and delayed inactivation, compared to WT myocytes (6 0.6 pA/
pF). In summary, we demonstrate that the LRRC10 and Cav1.2 subunit ofLTCC may directly interact with one another and that mutations in LRRC10
residues, likely important for protein-protein interactions, disrupts this associ-
ation. We conclude that LRRC10 is a novel and essential regulator of the LTCC
function in ventricular myocytes.
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Distinguishing between allostery and competition among modulating ligands is
challenging for large target molecules. One key example of such ambiguity
concerns calcium-binding proteins (CaBPs) that tune signaling molecules regu-
lated by calmodulin (CaM). In L-type Ca2þ channels, CaBPs can potently elim-
inate CaM-dependent inactivation (CDI). However, the mechanism for this
modulation remains controversial. In past, using a live-cell holomolecule
approach, we resolved a cyclical allosteric binding scheme for CaM and
CaBP4 to CaV1.3 channels. In this scheme, both CaBP4 and CaM can simulta-
neously bind, resulting in strong inhibition of CDI despite the presence of a
covalently attached CaM (a), supporting an allosteric regulatory mechanism.
By contrast, Findeisen et al (J Mol. Biol. 425(17):3217-34) showed that fusion
of CaM to CaV1.2 channels prevents CaBP1 modulation, thus arguing for a
competitive regulatory mechanism. These results are confounded by limited
delivery of CaBPs through pipet dialysis. Here, we show that the CDI of
CaV1.2 channels with a fused CaM is
robustly inhibited by recombinantly ex-
pressed CaBP1 and CaBP4 (b). Thus, it ap-
pears that the cyclical allosteric scheme
first resolved in CaV1.3 now stands as a
common framework for CaBP modulation
of L-type calcium channels.
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The Ca2þ currents in inner hair cells (IHCs) are crucial for synaptic transmis-
sion and flow through voltage-gated calcium channels (VGCCs) formed by the
a1 subunit Cav1.3. VGCCs exhibit a calmodulin (CaM) mediated calcium-
dependent inactivation (CDI), via binding CAM to the channel’s C-terminus.
In IHCs, Cav1.3 exhibits unusually weak CDI, probably caused by calcium
binding proteins (CaBP) competing with CaM. IHCs express long and short
Cav1.3 splice variants either including (long variant, Cav1.3L) or excluding
(short variants) a C-terminal modulatory domain. In expression systems - lack-
ing CaBPs - the C-terminal modulatory mechanism (CTM) functions via intra-
molecular interaction of a proximal (PCRD) and a distal C-terminal regulatory
domain (DCRD) by inhibiting CaM binding near the PCRD, thereby inhibiting
CaM-mediated CDI (Bock et al., JBC 2011). Here, the role of the CTM for IHC
VGCCs was investigated in Cav1.3L-DCRDHA/HA mice in which CTM was
disrupted by partial replacement of the DCRD with an HA tag.
Localization of HA-tagged Cav1.3 channels in IHCs was determined by immu-
nohistochemistry. Channel properties were investigated by whole-cell patch-
clamp recordings. Hearing was assessed using auditory brainstem responses
(ABR) and distortion products of otoacoustic emissions (DPOAE).
Anti-HA immunolabeling was present at all IHC ribbons. Patch-clamp record-
ings revealed significantly reduced CDI and increased amplitudes of Ca2þ and
Ba2þ currents in Cav1.3L-DCRDHA/HA IHCs. Non-stationary fluctuation
analysis showed unchanged numbers of Cav1.3 channels and single channel
currents. Voltage dependence and activation kinetics of ICa and IBa, ABR
thresholds and DPOAEs were unaffected.
Our data demonstrate that the long Cav1.3 isoform is an intrinsic component of
Cav1.3 clusters at all IHC ribbon synapses and that its DCRD is required for
normal CDI and ICa amplitude.
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